ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Molecular Genetics of Retinal Degenerations

This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), December 2007

Sponsored by: National Eye Institute (NEI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00231010
  Purpose

This multinational study will investigate the inheritance of genetic retinal degeneration in families of different nationalities and ethnic backgrounds in order to identify the genes that, when altered, cause retinal degeneration. The retina is a light-sensitive membrane lining the back part of the eye. It relays vision signals to the brain, which the brain interprets into sight. When the retina degenerates, vision is altered and possibly lost. The findings of this study should help improve diagnosis and methods of treatment for these disorders. Participating institutions include: the National Institutes for Health in Bethesda, Maryland; the University of Miami in Florida; the Casey Eye Institute in Portland, Oregon; the Byrd Health Sciences Center in Morgantown, West Virginia; the University of Texas Southwestern Medical School in Dallas, Texas; the University of Tennessee Health Sciences Center in Memphis; the Prasad Eye Institute in Hyderabad, India; National Center of Excellence in Molecular Biology in Lahore, Pakistan; and the Jules Gonin Hospital in Lausanne, Switzerland.

Patients with retinitis pigmentosa and closely related diseases such as Usher syndrome, snowflake vitreoretinal dystrophy and Bietti crystalline dystrophy may be eligible for this study. Participants undergo the following tests and procedures:

  • Medical and surgical history, including family history of vision problems.
  • Examination to clarify the type of retinal degeneration.
  • Eye examination, including tests of color vision, field of vision and ability to see in the dark
  • Electroretinogram to test the function of visual cells. For this test, the patient sits in a dark room for 30 minutes with his or her eyes patched. Then, a small electrode (silver disk) is taped to the forehead and the eye patches are removed. The surface the eyes is numbed with eye drops, and contact lenses are placed on the eyes. The patient looks inside a large dark globe that emits a series of light flashes. Then a light is turned on inside the globe and more lights flash. The contact lenses sense small electrical signals generated by the retina when the light flashes.
  • Hearing tests for patients with a personal or family history of deafness. Tests include an audiogram, ear examination and test of middle ear function. For middle ear function testing, the patient feels a little air pressure change for a moment and hears some tones. Another test requires the patient to sit quietly with electrodes on the head, forehead and earlobes.
  • Balance testing, including walking in a straight line, standing with eyes closed in the dark and other tests of coordination, and caloric testing. For the caloric testing, any ear wax in the ear canal is removed before the test begins. Then, electrodes are placed on the skin near the eyes and on the forehead. A small amount of cool (sometimes cold) or warm water is instilled into each ear canal, first one and then the other.
  • Blood sample collection for genetic testing.

Condition
Retinal Degeneration
Retinitis Pigmentosa

Genetics Home Reference related topics:   Lenz microphthalmia syndrome    oculofaciocardiodental syndrome    Peters plus syndrome    Usher syndrome    X-linked juvenile retinoschisis   

MedlinePlus related topics:   Usher Syndrome   

ChemIDplus related topics:   Tretinoin   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Molecular Genetics of Retinal Degenerations

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   2000
Study Start Date:   September 2005

Detailed Description:

This project, Molecular Genetics of Retinal Degenerations will study the inheritance of genetic retinal degenerations, both Mendelian and complex, in families of many nationalities and ethnic backgrounds in order to identify the genes that, when mutated, cause retinal degenerations and the pathophysiology through which they act. The number of subjects to be enrolled has no logical upper limit, but will be at least 250. The study consists of ascertaining individuals, and especially families with multiple individuals, affected by retinal degenerations including retinitis pigmentosa (RP) and also other closely related retinal degenerations such as Usher syndrome (USH) and Bietti crystalline dystrophy (BCD). These patients and their families will undergo detailed ophthalmological examinations and, where indicated, additional non-investigational examinations to characterize their retinal degeneration and determine their affectation status. A blood sample will be collected from each individual for isolation of DNA and in some individuals for lymphoblastoid transformation to establish a renewable source of DNA. Linkage analysis, physical mapping, and mutational screening will be carried out to identify the specific gene and the mutations in it that are associated with retinal degenerations in this family. If necessary, the gene product will be characterized biochemically. The principle investigator is James Fielding Hejtmancik at the OMGS/OGVFB/NEI. Associate investigators at the OGVFB/NEI include Dr. Raphael Caruso, and Dr. Benjamin Rubin. Associate investigators at collaborating institutions include Dr. Xuezhong Liu (University of Miami), Dr. Richard Welleber (University of Oregon), Dr. Monique Leys (West Virginia University), Dr. Chitra Kannabiran (L.. V. Prasad Eye Institute, Hyderabad, India), Dr. S. Riazuddin (Centre for Excellence in Molecular Biology, Lahore, Pakistan), Dr. Francis Muniere (Jules Gonin Eye Hospital, Lusanne, Switzerland), Dr. Albert Edwards (UT Southwestern Med. Ctr), and Dr. Allesandro Iannaccone (U Tenn Health Sci Ctr).

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • INCLUSION CRITERIA:

Patients that meet diagnostic criteria for specific retinal degenerations will be recruited from the NEI and collaborating clinics.

In addition, this protocol will include patients with other retinal degenerations, including retinitis pigmentosa and Bietti crystalline dystrophy, which have been excluded from the Gyrate atrophy protocol EI 78-001, in which they were formerly included.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00231010

Contacts
Contact: Patient Recruitment and Public Liaison Office     (800) 411-1222     prpl@mail.cc.nih.gov    
Contact: TTY     1-866-411-1010    

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike     Recruiting
      Bethesda, Maryland, United States, 20892
United States, Massachusetts
Harvard Medical School     Recruiting
      Boston, Massachusetts, United States, 02115
United States, Oregon
Casey Eye Institute     Recruiting
      Portland, Oregon, United States
United States, Texas
UT Southwestern Medical School     Recruiting
      Dallas, Texas, United States
Pakistan
University of Punjabv     Recruiting
      Lahore, Pakistan

Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   050143, 05-EI-0143
First Received:   September 30, 2005
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00231010
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Gene  
Mutation  
Retina  
Bietti  
Retnitis Pigmentosa  
Molecular  
Genetics  
Retinal  
Degeneration  
Usher
Retinal Degeneration
Retinitis Pigmentosa
RP
Usher Syndrome
USH
Bietti Crystalline Dystrophy
BCD

Study placed in the following topic categories:
Retinitis pigmentosa-deafness syndrome
Eye Diseases
Retinitis
Retinal Degeneration
Usher Syndromes
Pigmentary retinopathy
Genetic Diseases, Inborn
Retinitis Pigmentosa
Cone rod dystrophy
Tretinoin
Eye Diseases, Hereditary
Usher syndrome
Retinal Diseases
Retinal degeneration

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers